Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Sickle Cell Anemia
and you are
between 3 and 15
years old
The phase for this study is not defined.
Show me locations

The purpose

Prospective screening and treatment study for children with Sickle Cell Anemia and increased stroke risk living in the Dominican Republic.

Provided treatments

  • Drug: Hydroxyurea
  • Procedure: TCD examination
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02769845. The sponsor of the trial is Children's Hospital Medical Center, Cincinnati and it is looking for 500 volunteers for the current phase.
Official trial title:
Stroke Avoidance for Children in REpublica Dominicana (SACRED): A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia